中石化(00386.HK)與英力士訂資產交易 組合天津資建HDPE項目
中國石油化工股份(00386.HK)公布,與全球性石化產品製造商英力士若干子公司簽訂交易協議。據此,公司連同附屬高橋石化向英力士上海出售上海賽科合共50%股權,對價105.22億人民幣,其中,公司轉讓15%股權對價為31.57億人民幣。交易預計增加稅前利潤約121.83億人民幣;及公司向INEOS Styrolution APAC收購寧波苯領50%股權,現金代價6.31億美元,將以內部資源撥付。
此外,公司將與英力士天津成立HDPE合資,於天津建設50萬噸/年HDPE(高密度聚乙烯)項目,雙方分別持股50%,其中,公司投入註冊資本約6.23億人民幣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.